Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ting Zhu

Showing results (1-10 of 1,529) with videos related to

Pageof 153
Sort By:
Nature|September 15, 2025
Mirror of the unknown: should research on mirror-image molecular biology be stopped?Ting Zhu
Molecular Medicine Reports|April 12, 2011
Is it necessary to control the level of estrogen receptor α and β activation in postmenopausal hormone replacement therapy in order to achieve the optimal outcome? (Review)Bao Ting Zhu
International Journal of Molecular Medicine|February 10, 2004
CNS dopamine oxidation and catechol-O-methyltransferase: importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's diseaseBao Ting Zhu
Cells|February 15, 2022
Pathogenic Mechanism of Autoimmune Diabetes Mellitus in Humans: Potential Role of Streptozotocin-Induced Selective Autoimmunity against Human Islet <i>β</i>-CellsBao Ting Zhu
Journal of Molecular Cell Biology|November 19, 2025
Pathogenic Mechanism Underlying Parkinsonism Induced by Neurotoxicants (MPTP and 6-Hydroxydopamine) and α-Synuclein: A Unifying HypothesisBao Ting Zhu
Current Drug Metabolism|June 27, 2002
Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesisBao Ting Zhu
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 30, 2005
Mechanistic explanation for the unique pharmacologic properties of receptor partial agonistsBao Ting Zhu
Anti-Cancer Agents in Medicinal Chemistry|May 16, 2012
Natural compounds as cancer chemopreventive and chemotherapeutic agents: insights gained from mechanistic and pharmacologic studiesBao Ting Zhu
Expert Opinion on Drug Metabolism & Toxicology|February 2, 2010
On the general mechanism of selective induction of cytochrome P450 enzymes by chemicals: some theoretical considerationsBao Ting Zhu
International Journal of Oncology|February 13, 2003
Medical hypothesis: hyperhomocysteinemia is a risk factor for estrogen-induced hormonal cancerBao Ting Zhu
Pageof 153

Showing results (1-10 of 1,529) with videos related to

Sort By:
Pageof 153
Nature|September 15, 2025
Mirror of the unknown: should research on mirror-image molecular biology be stopped?Ting Zhu
Molecular Medicine Reports|April 12, 2011
Is it necessary to control the level of estrogen receptor α and β activation in postmenopausal hormone replacement therapy in order to achieve the optimal outcome? (Review)Bao Ting Zhu
International Journal of Molecular Medicine|February 10, 2004
CNS dopamine oxidation and catechol-O-methyltransferase: importance in the etiology, pharmacotherapy, and dietary prevention of Parkinson's diseaseBao Ting Zhu
Cells|February 15, 2022
Pathogenic Mechanism of Autoimmune Diabetes Mellitus in Humans: Potential Role of Streptozotocin-Induced Selective Autoimmunity against Human Islet <i>β</i>-CellsBao Ting Zhu
Journal of Molecular Cell Biology|November 19, 2025
Pathogenic Mechanism Underlying Parkinsonism Induced by Neurotoxicants (MPTP and 6-Hydroxydopamine) and α-Synuclein: A Unifying HypothesisBao Ting Zhu
Current Drug Metabolism|June 27, 2002
Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesisBao Ting Zhu
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 30, 2005
Mechanistic explanation for the unique pharmacologic properties of receptor partial agonistsBao Ting Zhu
Anti-Cancer Agents in Medicinal Chemistry|May 16, 2012
Natural compounds as cancer chemopreventive and chemotherapeutic agents: insights gained from mechanistic and pharmacologic studiesBao Ting Zhu
Expert Opinion on Drug Metabolism & Toxicology|February 2, 2010
On the general mechanism of selective induction of cytochrome P450 enzymes by chemicals: some theoretical considerationsBao Ting Zhu
International Journal of Oncology|February 13, 2003
Medical hypothesis: hyperhomocysteinemia is a risk factor for estrogen-induced hormonal cancerBao Ting Zhu
Pageof 153